| Price | 8.85p on 24-04-2026 at 18:50:09 |
|---|---|
| Change | -0.30p -3.28% |
| Buy | 9.00p |
| Sell | 8.70p |
| Last Trade: | Buy 28,134.00 at 8.886p |
| Day's Volume: | 1,585,924 |
| Last Close: | 8.85p |
| Open: | 9.05p |
| ISIN: | GB00BYV81293 |
| Day's Range | 8.85p - 9.05p |
| 52wk Range: | 2.25p - 12.35p |
| Market Capitalisation: | £94.56m |
| VWAP: | 8.831277p |
| Shares in Issue: | 1.07b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 28,134 | 8.886p | Ordinary |
16:27:15 - 24-Apr-26 |
| Sell* | 40,127 | 8.80p | Negotiated Trade |
16:15:34 - 24-Apr-26 |
| Buy* | 1,887 | 8.94p | Ordinary |
16:07:08 - 24-Apr-26 |
| Sell* | 30,000 | 8.75p | Ordinary |
16:06:27 - 24-Apr-26 |
| Sell* | 9 | 8.70p | SI Trade |
16:05:15 - 24-Apr-26 |
| Buy* | 44 | 9.00p | SI Trade |
16:05:15 - 24-Apr-26 |
| Buy* | 111 | 9.00p | SI Trade |
16:05:15 - 24-Apr-26 |
| Buy* | 15 | 9.00p | SI Trade |
16:05:15 - 24-Apr-26 |
| Buy* | 58 | 9.00p | SI Trade |
16:05:15 - 24-Apr-26 |
| Buy* | 22 | 9.00p | SI Trade |
16:05:15 - 24-Apr-26 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 9th Apr 2026 12:30 pm | RNS | Audited results for year ended 31 December 2025 |
| 1st Apr 2026 9:22 am | RNS-R | Publication of Report, Reinforcing FDA Approval |
| 31st Mar 2026 7:03 am | RNS | Total Voting Rights |
| 31st Mar 2026 7:00 am | RNS | EMA approves extension - to include adolescents |
| 3rd Mar 2026 7:00 am | RNS | Chinese NMPA Accepts MAA Submission for ACCRUFeR® |
| 27th Feb 2026 7:00 am | RNS | Total Voting Rights |
| 9th Feb 2026 7:00 am | RNS | FDA Grants additional Exclusivity for ACCRUFeR |
| 30th Jan 2026 7:05 am | RNS | Total Voting Rights |
| 30th Jan 2026 7:00 am | RNS | Approval for ACCRUFeR in China expected in Q1 2026 |
| 21st Jan 2026 7:00 am | RNS | Q4 2025 Trading Update |
